DNA Ligase Short: The Enzyme That Seals DNA Breaks

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

DNA is the most chemically stable macromolecule in the cell, yet it is constantly damaged. Every cell in your body experiences tens of thousands of DNA lesions per day—from ultraviolet light, reactive oxygen species, replication errors, and even spontaneous hydrolysis. Without a dedicated machinery to repair these breaks, the genome would fragment, and the cell would die. At the center of this repair machinery sits a small but essential enzyme: DNA ligase.

DNA ligase short refers to the abbreviated form of the enzyme that catalyzes the final step in joining two DNA strands—the formation of a phosphodiester bond between the 3′ hydroxyl group of one nucleotide and the 5′ phosphate group of the next. It is the "molecular glue" of the genome. Without it, DNA replication would produce discontinuous fragments, and DNA repair would remain incomplete. This article explains what DNA ligase is, how it works, why it matters, and how scientists study and use it.

What Is DNA Ligase Short?

DNA ligase is an enzyme that catalyzes the covalent joining of two DNA strands. The term "DNA ligase short" is not a distinct isoform found in nature; rather, it is a convenient shorthand used in textbooks and laboratory settings to refer to the core catalytic function of the enzyme—the sealing of nicks in the DNA backbone. A nick is a break in one strand of the double helix where the sugar-phosphate backbone is interrupted, but the complementary strand remains intact.

The full-length DNA ligase proteins in different organisms range from about 55 to 100 kilodaltons, but the catalytic core—the domain responsible for the ligation reaction—is highly conserved across all domains of life. This conserved core is what the term "DNA ligase short" captures: the essential enzymatic activity that joins DNA ends.

The reaction catalyzed by DNA ligase is:

5′-phosphate + 3′-hydroxyl → phosphodiester bond

This reaction requires energy. In most organisms, the energy comes from ATP (adenosine triphosphate), while in some bacteria, it comes from NAD⁺ (nicotinamide adenine dinucleotide). The enzyme first uses this energy to activate itself, then transfers the activated group to the DNA, and finally seals the break. We will examine this mechanism in detail later.

DNA ligase is essential for three major biological processes: DNA replication, DNA repair, and DNA recombination. In each case, the enzyme performs the same chemical reaction—joining two DNA strands—but in different contexts and with different partner proteins.

The Role of DNA Ligase in DNA Replication

DNA replication is the process by which a cell duplicates its entire genome before division. The replication machinery is a complex of many proteins working together at a structure called the replication fork short. The fork is the Y-shaped region where the double helix unwinds and new strands are synthesized.

DNA polymerases—the enzymes that synthesize new DNA—can only add nucleotides in the 5′ to 3′ direction. This creates a problem. On the leading strand, synthesis is continuous because the template is oriented in the correct direction. On the lagging strand, however, the template runs in the opposite direction, forcing the polymerase to synthesize short, discontinuous pieces of DNA called Okazaki fragments.

Okazaki Fragments and Lagging Strand Synthesis

Okazaki fragments are short stretches of DNA, typically 100–200 nucleotides long in eukaryotes and 1,000–2,000 nucleotides long in bacteria. Each fragment is initiated by a short RNA primer, synthesized by an enzyme called primase, and then extended by DNA polymerase.

Once a fragment is complete, the RNA primer must be removed and replaced with DNA. In bacteria, this is done by DNA polymerase I, which has both exonuclease activity (to remove the RNA) and polymerase activity (to fill the gap). In eukaryotes, the removal is more complex and involves the enzyme flap endonuclease 1 (FEN1) and the nuclease Dna2.

After the RNA primer is removed and replaced, a nick remains between the 3′ end of the newly synthesized DNA and the 5′ end of the next Okazaki fragment. This nick is a single-strand break—the sugar-phosphate backbone is interrupted, and the two fragments are not covalently connected.

This is where DNA ligase enters. In bacteria, the enzyme DNA ligase (encoded by the ligA gene) seals these nicks. In eukaryotes, the job falls to DNA ligase I (encoded by the LIG1 gene). DNA ligase I is specifically recruited to the replication fork through its interaction with proliferating cell nuclear antigen (PCNA), the sliding clamp that processivity factor for DNA polymerase.

The ligation of Okazaki fragments is the final step in lagging strand synthesis. Without it, the lagging strand would remain as a series of disconnected fragments, and the newly replicated DNA would contain numerous single-strand breaks. These breaks would be converted to double-strand breaks during the next round of replication, leading to genome instability and cell death.

DNA Ligase in DNA Repair

DNA is under constant attack from endogenous and exogenous agents. Some of these attacks create single-strand breaks directly, while others create base damage that must be removed through repair pathways. In all cases, the final step—sealing the remaining nick—requires DNA ligase.

Base Excision Repair

Base excision repair (BER) handles the most common type of DNA damage: small, non-bulky lesions such as oxidized bases, alkylated bases, and uracil (which arises from spontaneous deamination of cytosine). The pathway begins with a DNA glycosylase, an enzyme that recognizes the damaged base and removes it by cleaving the glycosidic bond, leaving an abasic (AP) site.

Next, an AP endonuclease (APE1 in humans) cuts the DNA backbone at the AP site, creating a single-strand break with a 3′ hydroxyl group and a 5′ deoxyribose phosphate (dRP) group. In short-patch BER, DNA polymerase β then adds a single nucleotide and removes the 5′ dRP group using its lyase activity. The result is a nick with a 3′ hydroxyl and a 5′ phosphate—the perfect substrate for DNA ligase.

In humans, DNA ligase III (encoded by the LIG3 gene) is the primary ligase in short-patch BER. DNA ligase III exists in two forms: a nuclear form and a mitochondrial form. The nuclear form contains a zinc finger domain that allows it to bind to nicked DNA with high affinity. It also interacts with the scaffolding protein XRCC1, which coordinates the BER pathway by bringing together the glycosylase, the endonuclease, the polymerase, and the ligase.

In long-patch BER, where 2–10 nucleotides are replaced, DNA ligase I performs the final ligation step. The choice between short-patch and long-patch BER depends on the type of damage and the phase of the cell cycle.

Nucleotide Excision Repair

Nucleotide excision repair (NER) handles bulky, helix-distorting lesions such as those caused by ultraviolet light (pyrimidine dimers) and chemical carcinogens. In NER, a complex of proteins recognizes the damage, unwinds the DNA around the lesion, and makes incisions on both sides of the damage, releasing a 24–32 nucleotide single-stranded fragment.

The gap is then filled by DNA polymerases δ or ε, and the remaining nick is sealed by DNA ligase. In humans, DNA ligase I is the primary ligase for NER, although DNA ligase III may also participate in some contexts. The ligation step is essential for restoring the intact DNA duplex; without it, the repair would be incomplete, and the cell would retain a single-strand break that could be converted to a double-strand break during replication.

DNA ligase also participates in other repair pathways, including mismatch repair (where it seals the nick after the mismatched segment is removed) and double-strand break repair by non-homologous end joining (where DNA ligase IV, in complex with XRCC4, joins the two broken ends).

How DNA Ligase Works: The Mechanism

The ligation reaction is a three-step process that requires energy. The energy source differs between organisms: ATP in eukaryotes and most bacteriophages, NAD⁺ in most bacteria. The mechanism, however, is fundamentally the same.

Activation and Adenylation

The first step is the activation of the enzyme. DNA ligase binds to either ATP or NAD⁺ and cleaves it, releasing pyrophosphate (from ATP) or nicotinamide mononucleotide (from NAD⁺). The AMP (adenosine monophosphate) moiety is then covalently attached to a lysine residue in the active site of the enzyme. This forms a covalent enzyme-AMP intermediate, a process called adenylation.

The adenylation step is essential because it stores the energy needed for the subsequent bond formation. The enzyme-AMP intermediate is stable and can be isolated in vitro. In fact, the detection of this intermediate is a common assay for ligase activity.

Sealing the Break

In the second step, the AMP is transferred from the enzyme to the 5′ phosphate group at the nick. This creates a new intermediate: the DNA is now adenylated at the 5′ end, with a pyrophosphate linkage (5′-AMP) at the break site. This activates the 5′ phosphate, making it a good leaving group.

In the third step, the 3′ hydroxyl group of the adjacent nucleotide attacks the activated 5′ phosphate, displacing the AMP and forming a new phosphodiester bond. The AMP is released, and the DNA backbone is now continuous.

The overall reaction can be written as:

DNA (nicked) + ATP (or NAD⁺) → DNA (sealed) + AMP + PPi (or NMN)

The DNA ligase reaction is reversible in theory, but the hydrolysis of the pyrophosphate by inorganic pyrophosphatase drives the reaction forward in the cell.

The mechanism is highly specific. DNA ligase will only join a 3′ hydroxyl to a 5′ phosphate; it will not join two 5′ ends or two 3′ ends. It also requires that the two ends be properly base-paired with the complementary strand. This specificity ensures that ligation only occurs at nicks, not at random locations.

Types of DNA Ligases

DNA ligases are found in all organisms, but they differ in their energy source, structure, and cellular roles. The two major classes are NAD⁺-dependent ligases (found in bacteria) and ATP-dependent ligases (found in eukaryotes, archaea, and bacteriophages).

Prokaryotic vs. Eukaryotic Ligases

Bacterial DNA ligase (LigA). Escherichia coli has a single DNA ligase, encoded by the ligA gene. This enzyme uses NAD⁺ as its energy source, a feature unique to bacterial ligases. The NAD⁺-dependent ligase is an attractive target for antibacterial drugs because humans do not have this type of ligase. The enzyme is essential for bacterial viability; mutations in ligA are lethal.

Bacteriophage T4 DNA ligase. The T4 phage encodes its own ATP-dependent DNA ligase, which is the most widely used ligase in molecular biology. T4 DNA ligase is unusual in that it can join blunt-ended DNA molecules, not just sticky ends. This property makes it invaluable for cloning. The enzyme works optimally at 37°C but is typically used at 16°C overnight to balance activity and stability. The standard reaction buffer contains 50 mM Tris-HCl (pH 7.5), 10 mM MgCl₂, 10 mM DTT, and 1 mM ATP.

Human DNA ligases. Humans have three genes encoding DNA ligases: LIG1, LIG3, and LIG4. (A fourth gene, LIG2, is a pseudogene.) Each encodes a distinct enzyme with specific roles:

DNA ligase I is a 102 kDa protein that is predominantly nuclear and is essential for DNA replication. Mutations in LIG1 cause a rare immunodeficiency syndrome characterized by sensitivity to DNA-damaging agents. DNA ligase III is unique in that it contains a mitochondrial targeting sequence; the mitochondrial form is essential for maintaining mitochondrial genome integrity. DNA ligase IV is exclusively involved in NHEJ, the major pathway for repairing double-strand breaks in G0/G1 phase. Mutations in LIG4 cause LIG4 syndrome, a severe immunodeficiency disorder with developmental abnormalities.

Studying DNA Ligase: Methods and Experiments

DNA ligase has been studied extensively since its discovery in the 1960s. The methods used to study it range from simple biochemical assays to sophisticated structural biology techniques.

Ligase Assays

The most basic assay for DNA ligase activity is the nick-joining assay. A short double-stranded DNA substrate is prepared with a nick in one strand—a 3′ hydroxyl on one side and a 5′ phosphate on the other. The 5′ end is labeled with a radioactive phosphate (³²P) or a fluorescent dye. The ligase is added, and the reaction is allowed to proceed. The products are then separated by denaturing polyacrylamide gel electrophoresis. If ligation occurred, the labeled fragment will be longer (because it is now joined to the adjacent fragment). The appearance of the longer product indicates ligase activity.

A more quantitative assay is the AMP release assay. Because the ligase reaction releases AMP, one can measure ligase activity by tracking the conversion of [³²P]-NAD⁺ (for bacterial ligase) or [³²P]-ATP (for eukaryotic ligase) to [³²P]-AMP. This assay is useful for determining kinetic parameters such as K_m and V_max.

For high-throughput screening, researchers often use a fluorescence resonance energy transfer (FRET)-based assay. A DNA substrate is labeled with a fluorophore at one end and a quencher at the other. When the nick is sealed, the two ends are brought into proximity, and the fluorescence is quenched. The decrease in fluorescence is proportional to ligase activity.

Mutational Analysis

Mutagenesis is a powerful tool for understanding the mechanism of DNA ligase. By introducing specific amino acid changes, researchers can identify residues that are critical for catalysis, substrate binding, or protein-protein interactions.

For example, the active site lysine that becomes adenylated is absolutely conserved across all DNA ligases. Mutating this lysine to alanine abolishes ligase activity entirely. Similarly, mutations in the nucleotide-binding pocket can change the enzyme's preference for ATP versus NAD⁺.

Mutational analysis has also revealed the importance of the BRCT domain (BRCA1 C-terminal domain) in DNA ligases III and IV. This domain mediates protein-protein interactions with XRCC1 and XRCC4, respectively. Deleting the BRCT domain does not abolish catalytic activity but does abolish the ability of the ligase to function in the cell, because it can no longer be recruited to the site of damage.

DNA Ligase in Biotechnology and Medicine

DNA ligase is not just a biological curiosity; it is a workhorse of molecular biology and a promising therapeutic target.

Molecular Cloning

The most common use of DNA ligase is in molecular cloning. The goal of cloning is to insert a piece of foreign DNA (the insert) into a vector (such as a plasmid), creating a recombinant DNA molecule. This requires joining the insert to the vector, and DNA ligase performs this joining.

The standard procedure is as follows:

1. Digest the vector and insert with restriction enzymes to create compatible ends.
2. Mix the vector and insert in a molar ratio of approximately 1:3 (vector:insert) in a ligation buffer.
3. Add T4 DNA ligase (typically 1–2 units per 20 µL reaction).
4. Incubate at 16°C for 4–16 hours (or at room temperature for 30 minutes to 1 hour for sticky-end ligations).
5. Transform the ligation mixture into competent E. coli cells.

The DNA ligase join sticky ends with high efficiency because the complementary overhangs hold the two DNA molecules together, increasing the local concentration of the ends. Blunt-end ligation is less efficient and requires higher concentrations of ligase and DNA.

T4 DNA ligase is the enzyme of choice for most cloning applications because it can join both sticky and blunt ends. The thermo T4 DNA ligase from the T4 bacteriophage is available from commercial suppliers and is highly purified.

DNA ligase is also used in DNA sequencing library preparation, where it ligates adapters to fragmented DNA, and in polymerase chain reaction (PCR) cloning, where it is used to join PCR products into vectors. The broader field of DNA ligase in genetic engineering encompasses all these applications.

Medical Implications

Because DNA ligase is essential for DNA replication and repair, it is an attractive target for anticancer drugs. Cancer cells divide rapidly and rely heavily on DNA repair to survive the DNA damage caused by chemotherapy and radiation. Inhibiting DNA ligase could sensitize cancer cells to these treatments.

Several DNA ligase inhibitors have been identified, including natural products such as liriodenine and synthetic compounds such as compound 1a (a glycosylureide). These inhibitors bind to the enzyme's active site and prevent adenylation, thereby blocking ligation. Preclinical studies have shown that these inhibitors can enhance the cytotoxicity of DNA-damaging agents in cancer cell lines.

DNA ligase IV is a particularly attractive target because it is only involved in NHEJ, and NHEJ is often upregulated in cancer cells. Inhibiting ligase IV could selectively kill cancer cells that rely on NHEJ for survival.

Conversely, DNA ligase deficiency in humans causes severe disease. Mutations in LIG1 cause a syndrome of growth retardation, immunodeficiency, and sensitivity to sunlight. Mutations in LIG4 cause LIG4 syndrome, characterized by severe combined immunodeficiency, developmental delay, and radiation sensitivity. These conditions highlight the essential role of DNA ligase in maintaining genome integrity.

Common Misconceptions and Pitfalls

Despite its importance, DNA ligase is often misunderstood. Here are some common pitfalls and misconceptions.

Ligase vs. Polymerase

The most common confusion is between DNA ligase and DNA polymerase. Both enzymes act on DNA, but they do very different things:

• DNA polymerase synthesizes new DNA by adding nucleotides one at a time, using a template strand as a guide. It extends a primer by forming phosphodiester bonds between the incoming nucleotide and the growing chain.
• DNA ligase does not add nucleotides. It joins two pre-existing DNA strands by forming a phosphodiester bond between the 3′ hydroxyl of one strand and the 5′ phosphate of the adjacent strand.

Think of it this way: polymerase is the builder that lays down new bricks, while ligase is the worker that cements the bricks together. You cannot replace one with the other.

Energy Requirement

Another misconception is that DNA ligase works without energy. This is incorrect. The formation of a phosphodiester bond is thermodynamically unfavorable; it requires an input of energy. DNA ligase obtains this energy from ATP (in eukaryotes) or NAD⁺ (in bacteria). Without this energy source, the ligase cannot function.

This is why ligation buffers always contain ATP. If you forget to add ATP to your ligation reaction, the reaction will fail. Similarly, if the ATP is hydrolyzed during storage (which can happen if the buffer is old or contaminated with phosphatases), the ligase will not work.

Substrate Specificity

A third misconception is that DNA ligase can join any two DNA ends. In reality, DNA ligase is highly specific. It will only join a 3′ hydroxyl to a 5′ phosphate, and it requires that the two ends be properly base-paired with the complementary strand. It will not join single-stranded DNA, and it will not join mismatched ends.

This specificity is a feature, not a bug. It ensures that ligation only occurs at nicks, where the two ends are correctly positioned. If ligase were promiscuous, it would create random joins throughout the genome, leading to chaos.

Blunt-End Ligation Efficiency

A practical pitfall in the lab is underestimating the difficulty of blunt-end ligation. Many beginners assume that blunt-end ligation is as efficient as sticky-end ligation. It is not. Blunt-end ligation requires approximately 10–100 times more ligase and DNA, and the reaction must be incubated for longer (typically overnight at 16°C). The efficiency can be improved by using higher concentrations of DNA, adding PEG (polyethylene glycol) to the reaction, or using a ligase with enhanced blunt-end activity.

Summary and Key Takeaways

DNA ligase is a small but essential enzyme that seals breaks in the DNA backbone. It is required for DNA replication, DNA repair, and DNA recombination. The enzyme works by a three-step mechanism that requires energy from ATP or NAD⁺. Different organisms have different types of DNA ligase, each specialized for particular cellular roles. In the laboratory, DNA ligase is used for molecular cloning and other genetic engineering applications. In medicine, it is a target for anticancer drugs, and its deficiency causes severe human diseases.

Frequently Asked Questions

What is DNA ligase short?

DNA ligase short is a shorthand term for the core catalytic function of DNA ligase—the enzyme that joins two DNA strands by forming a phosphodiester bond between the 3′ hydroxyl of one strand and the 5′ phosphate of the adjacent strand. It is the "molecular glue" that seals nicks in the DNA backbone.

What does DNA ligase do?

DNA ligase seals nicks in the DNA backbone. It joins Okazaki fragments during DNA replication, completes DNA repair pathways, and participates in DNA recombination. Without DNA ligase, DNA would remain fragmented, and the genome would be unstable.

How does DNA ligase work?

DNA ligase works in three steps. First, it uses ATP (or NAD⁺) to adenylate itself, forming a covalent enzyme-AMP intermediate. Second, it transfers the AMP to the 5′ phosphate at the nick, activating it. Third, the 3′ hydroxyl attacks the activated 5′ phosphate, forming a new phosphodiester bond and releasing AMP.

Why is DNA ligase important?

DNA ligase is essential for life. It is required for DNA replication (to join Okazaki fragments), for DNA repair (to seal nicks after damaged bases are removed), and for DNA recombination. Defects in DNA ligase cause severe human diseases, and inhibition of DNA ligase is a strategy for cancer therapy.

What is the difference between DNA ligase and DNA polymerase?

DNA polymerase synthesizes new DNA by adding nucleotides one at a time, using a template strand. DNA ligase joins two pre-existing DNA strands; it does not add nucleotides. Polymerase builds, ligase seals.

Where is DNA ligase found?

DNA ligase is found in all organisms. In bacteria, it is a single enzyme that uses NAD⁺. In eukaryotes, there are three main ligases (I, III, and IV) that use ATP. DNA ligase is found in the nucleus (where it acts on nuclear DNA) and in mitochondria (where it maintains the mitochondrial genome).

What happens if DNA ligase is defective?

If DNA ligase is defective, DNA replication is incomplete (Okazaki fragments are not joined), DNA repair is incomplete (nicks remain), and the genome becomes unstable. In humans, mutations in LIG1 cause growth retardation and immunodeficiency, while mutations in LIG4 cause severe combined immunodeficiency and radiation sensitivity. In bacteria, loss of ligase is lethal.

Key Takeaways

• DNA ligase is the enzyme that seals nicks in the DNA backbone by forming phosphodiester bonds.
• It is essential for DNA replication, where it joins Okazaki fragments on the lagging strand.
• It is essential for DNA repair, including base excision repair and nucleotide excision repair.
• The ligation reaction requires energy from ATP or NAD⁺ and proceeds through a covalent enzyme-AMP intermediate.
• Different organisms have different types of DNA ligase: bacteria have NAD⁺-dependent ligase, while eukaryotes have ATP-dependent ligases I, III, and IV.
• DNA ligase is a workhorse of molecular biology, used in cloning, sequencing, and genetic engineering.
• DNA ligase is a therapeutic target for anticancer drugs, and its deficiency causes severe human diseases.

Related Clinical & Scientific Guides

• MAPK Pathway: Mechanism, Function, and Clinical Relevance
• Mammalian Cell Culture Bioreactors: A Practical Guide
• Nucleotide Formation: Biosynthesis and Assembly of DNA/RNA Building Blocks